Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative UO1 Grant

Trial Profile

Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative UO1 Grant

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 09 Apr 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tesamorelin (Primary)
  • Indications Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Apr 2020 Results assessing Clinical Predictors of Liver Fibrosis Presence and Progression in HIV-Associated NAFLD published in the Clinical Infectious Diseases
    • 11 Mar 2020 Results presented at the 27th Conference on Retroviruses and Opportunistic Infections
    • 11 Mar 2020 According to an Theratechnologies media release, the sub analysis evaluating the effect of drug on the excess visceral adiposity in the progression of fibrosis among HIV-infected patients from this study were presented at the CROI 2020. Dr. Lindsay Fourman, from Harvard Medical School, presented this data.
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top